Spontaneous splenic infarction associated with sumatriptan use
© Springer-Verlag Italia 2006
Received: 16 April 2006
Accepted: 18 May 2006
Published: 15 June 2006
Triptans are specific agonists of the serotonergic 5-HT1B/1D receptors that have increasingly been used in the treatment of migraine and cluster headaches. Though they are generally considered safe, there have been a few reports of myocardial infarction and stroke associated with triptan use. We report a patient who developed spontaneous splenic infarction after the use of sumatriptan for the treatment of migraine headache.